Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

Standard

Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients. / Greijdanus, Nynke G; Wienholts, Kiedo; Ubels, Sander; Talboom, Kevin; Hannink, Gerjon; Wolthuis, Albert; de Lacy, F Borja; Lefevre, Jérémie H; Solomon, Michael; Frasson, Matteo; Rotholtz, Nicolas; Denost, Quentin; Perez, Rodrigo O; Konishi, Tsuyoshi; Panis, Yves; Rutegård, Martin; Hompes, Roel; Rosman, Camiel; van Workum, Frans; Tanis, Pieter J; de Wilt, Johannes H W; TENTACLE-Rectum Collaborative Group.

In: BRIT J SURG, Vol. 110, No. 12, 09.11.2023, p. 1863-1876.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Greijdanus, NG, Wienholts, K, Ubels, S, Talboom, K, Hannink, G, Wolthuis, A, de Lacy, FB, Lefevre, JH, Solomon, M, Frasson, M, Rotholtz, N, Denost, Q, Perez, RO, Konishi, T, Panis, Y, Rutegård, M, Hompes, R, Rosman, C, van Workum, F, Tanis, PJ, de Wilt, JHW & TENTACLE-Rectum Collaborative Group 2023, 'Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients', BRIT J SURG, vol. 110, no. 12, pp. 1863-1876. https://doi.org/10.1093/bjs/znad311

APA

Greijdanus, N. G., Wienholts, K., Ubels, S., Talboom, K., Hannink, G., Wolthuis, A., de Lacy, F. B., Lefevre, J. H., Solomon, M., Frasson, M., Rotholtz, N., Denost, Q., Perez, R. O., Konishi, T., Panis, Y., Rutegård, M., Hompes, R., Rosman, C., van Workum, F., ... TENTACLE-Rectum Collaborative Group (2023). Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients. BRIT J SURG, 110(12), 1863-1876. https://doi.org/10.1093/bjs/znad311

Vancouver

Greijdanus NG, Wienholts K, Ubels S, Talboom K, Hannink G, Wolthuis A et al. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients. BRIT J SURG. 2023 Nov 9;110(12):1863-1876. https://doi.org/10.1093/bjs/znad311

Bibtex

@article{c4c7429de4ef41ba9866e5958be30ea3,
title = "Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients",
abstract = "BACKGROUND: The optimal treatment of anastomotic leak after rectal cancer resection is unclear. This worldwide cohort study aimed to provide an overview of four treatment strategies applied.METHODS: Patients from 216 centres and 45 countries with anastomotic leak after rectal cancer resection between 2014 and 2018 were included. Treatment was categorized as salvage surgery, faecal diversion with passive or active (vacuum) drainage, and no primary/secondary faecal diversion. The primary outcome was 1-year stoma-free survival. In addition, passive and active drainage were compared using propensity score matching (2 : 1).RESULTS: Of 2470 evaluable patients, 388 (16.0 per cent) underwent salvage surgery, 1524 (62.0 per cent) passive drainage, 278 (11.0 per cent) active drainage, and 280 (11.0 per cent) had no faecal diversion. One-year stoma-free survival rates were 13.7, 48.3, 48.2, and 65.4 per cent respectively. Propensity score matching resulted in 556 patients with passive and 278 with active drainage. There was no statistically significant difference between these groups in 1-year stoma-free survival (OR 0.95, 95 per cent c.i. 0.66 to 1.33), with a risk difference of -1.1 (95 per cent c.i. -9.0 to 7.0) per cent. After active drainage, more patients required secondary salvage surgery (OR 2.32, 1.49 to 3.59), prolonged hospital admission (an additional 6 (95 per cent c.i. 2 to 10) days), and ICU admission (OR 1.41, 1.02 to 1.94). Mean duration of leak healing did not differ significantly (an additional 12 (-28 to 52) days).CONCLUSION: Primary salvage surgery or omission of faecal diversion likely correspond to the most severe and least severe leaks respectively. In patients with diverted leaks, stoma-free survival did not differ statistically between passive and active drainage, although the increased risk of secondary salvage surgery and ICU admission suggests residual confounding.",
keywords = "Humans, Anastomotic Leak/etiology, Cohort Studies, Anastomosis, Surgical/methods, Rectum/surgery, Rectal Neoplasms/surgery, Retrospective Studies",
author = "Greijdanus, {Nynke G} and Kiedo Wienholts and Sander Ubels and Kevin Talboom and Gerjon Hannink and Albert Wolthuis and {de Lacy}, {F Borja} and Lefevre, {J{\'e}r{\'e}mie H} and Michael Solomon and Matteo Frasson and Nicolas Rotholtz and Quentin Denost and Perez, {Rodrigo O} and Tsuyoshi Konishi and Yves Panis and Martin Ruteg{\aa}rd and Roel Hompes and Camiel Rosman and {van Workum}, Frans and Tanis, {Pieter J} and {de Wilt}, {Johannes H W} and {TENTACLE-Rectum Collaborative Group} and Julia-Kristin Gra{\ss} and Melling, {Nathaniel Timon} and Simone Schewe",
note = "{\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.",
year = "2023",
month = nov,
day = "9",
doi = "10.1093/bjs/znad311",
language = "English",
volume = "110",
pages = "1863--1876",
journal = "BRIT J SURG",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

AU - Greijdanus, Nynke G

AU - Wienholts, Kiedo

AU - Ubels, Sander

AU - Talboom, Kevin

AU - Hannink, Gerjon

AU - Wolthuis, Albert

AU - de Lacy, F Borja

AU - Lefevre, Jérémie H

AU - Solomon, Michael

AU - Frasson, Matteo

AU - Rotholtz, Nicolas

AU - Denost, Quentin

AU - Perez, Rodrigo O

AU - Konishi, Tsuyoshi

AU - Panis, Yves

AU - Rutegård, Martin

AU - Hompes, Roel

AU - Rosman, Camiel

AU - van Workum, Frans

AU - Tanis, Pieter J

AU - de Wilt, Johannes H W

AU - TENTACLE-Rectum Collaborative Group

AU - Graß, Julia-Kristin

AU - Melling, Nathaniel Timon

AU - Schewe, Simone

N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.

PY - 2023/11/9

Y1 - 2023/11/9

N2 - BACKGROUND: The optimal treatment of anastomotic leak after rectal cancer resection is unclear. This worldwide cohort study aimed to provide an overview of four treatment strategies applied.METHODS: Patients from 216 centres and 45 countries with anastomotic leak after rectal cancer resection between 2014 and 2018 were included. Treatment was categorized as salvage surgery, faecal diversion with passive or active (vacuum) drainage, and no primary/secondary faecal diversion. The primary outcome was 1-year stoma-free survival. In addition, passive and active drainage were compared using propensity score matching (2 : 1).RESULTS: Of 2470 evaluable patients, 388 (16.0 per cent) underwent salvage surgery, 1524 (62.0 per cent) passive drainage, 278 (11.0 per cent) active drainage, and 280 (11.0 per cent) had no faecal diversion. One-year stoma-free survival rates were 13.7, 48.3, 48.2, and 65.4 per cent respectively. Propensity score matching resulted in 556 patients with passive and 278 with active drainage. There was no statistically significant difference between these groups in 1-year stoma-free survival (OR 0.95, 95 per cent c.i. 0.66 to 1.33), with a risk difference of -1.1 (95 per cent c.i. -9.0 to 7.0) per cent. After active drainage, more patients required secondary salvage surgery (OR 2.32, 1.49 to 3.59), prolonged hospital admission (an additional 6 (95 per cent c.i. 2 to 10) days), and ICU admission (OR 1.41, 1.02 to 1.94). Mean duration of leak healing did not differ significantly (an additional 12 (-28 to 52) days).CONCLUSION: Primary salvage surgery or omission of faecal diversion likely correspond to the most severe and least severe leaks respectively. In patients with diverted leaks, stoma-free survival did not differ statistically between passive and active drainage, although the increased risk of secondary salvage surgery and ICU admission suggests residual confounding.

AB - BACKGROUND: The optimal treatment of anastomotic leak after rectal cancer resection is unclear. This worldwide cohort study aimed to provide an overview of four treatment strategies applied.METHODS: Patients from 216 centres and 45 countries with anastomotic leak after rectal cancer resection between 2014 and 2018 were included. Treatment was categorized as salvage surgery, faecal diversion with passive or active (vacuum) drainage, and no primary/secondary faecal diversion. The primary outcome was 1-year stoma-free survival. In addition, passive and active drainage were compared using propensity score matching (2 : 1).RESULTS: Of 2470 evaluable patients, 388 (16.0 per cent) underwent salvage surgery, 1524 (62.0 per cent) passive drainage, 278 (11.0 per cent) active drainage, and 280 (11.0 per cent) had no faecal diversion. One-year stoma-free survival rates were 13.7, 48.3, 48.2, and 65.4 per cent respectively. Propensity score matching resulted in 556 patients with passive and 278 with active drainage. There was no statistically significant difference between these groups in 1-year stoma-free survival (OR 0.95, 95 per cent c.i. 0.66 to 1.33), with a risk difference of -1.1 (95 per cent c.i. -9.0 to 7.0) per cent. After active drainage, more patients required secondary salvage surgery (OR 2.32, 1.49 to 3.59), prolonged hospital admission (an additional 6 (95 per cent c.i. 2 to 10) days), and ICU admission (OR 1.41, 1.02 to 1.94). Mean duration of leak healing did not differ significantly (an additional 12 (-28 to 52) days).CONCLUSION: Primary salvage surgery or omission of faecal diversion likely correspond to the most severe and least severe leaks respectively. In patients with diverted leaks, stoma-free survival did not differ statistically between passive and active drainage, although the increased risk of secondary salvage surgery and ICU admission suggests residual confounding.

KW - Humans

KW - Anastomotic Leak/etiology

KW - Cohort Studies

KW - Anastomosis, Surgical/methods

KW - Rectum/surgery

KW - Rectal Neoplasms/surgery

KW - Retrospective Studies

U2 - 10.1093/bjs/znad311

DO - 10.1093/bjs/znad311

M3 - SCORING: Journal article

C2 - 37819790

VL - 110

SP - 1863

EP - 1876

JO - BRIT J SURG

JF - BRIT J SURG

SN - 0007-1323

IS - 12

ER -